Development Uses Clause Samples

The "Development Uses" clause defines how a party may use certain materials, information, or intellectual property specifically for development purposes. Typically, this clause outlines the scope of permitted activities, such as testing, prototyping, or internal evaluation, and may restrict commercial exploitation or distribution during the development phase. Its core function is to clarify the boundaries of use during development, ensuring both parties understand what is allowed and preventing unauthorized or premature commercial use.
Development Uses. The Project will include development of up to 333 market rate and affordable residential multi-family units on the Property in accordance with the approved Zoning, Text Amendment, and the UDO. The number and location of buildings, lots, parking areas, and interior drives will be shown on the site plan (the “Site Plan”) to be prepared by Developer following execution of this Agreement and reviewed administratively by Town staff.
View SourceView Similar (2)
Development Uses. The Project is, has been and shall be developed with the following components: • Phosphate mining activities, beneficiation activities, transportation of sand and clay, transportation activities and reclamation activities pursuant to the Master Mining Plan Res. R-13-001, to be amended forthwith by R-18-012.
View SourceView Similar (2)
Development Uses. The development uses for the DRI are set forth in the Development Order and the DRI Master Plan Map H, that are being revised concurrently with the adoption of this 2017 Development Agreement, and as may be amended in the future (“Map H”). The specific development uses of each of the Properties are governed by the following zoning ordinances, each as has been or may be amended from time to time: (i) as to the Bridgewater Property, City Ordinance No. 4322 (“Villages Zoning Approval”); (ii) as to the I-433 Property, City Ordinance Nos. 4191 and 4192 (“I-433 Zoning Approval”); (iii) as to the Long Lake Property, City Ordinance No. 4191 (“Long Lake Zoning Approval”); and as to the Ridge Property, City Ordinance No. (“Ridge Zoning
View Source
Development Uses. The Property shall be developed as a 69-lot subdivision in accordance with the Conceptual Plan attached hereto as Exhibit “C.” The minimum lot sizes, and setbacks, and other applicable development standards shall be as depicted in the PUD Agreement to be executed at the time of the rezoning.
View Source
Development Uses. In accordance with G.S. 160A-400.25(a)(3), a broad range of residential, institutional, and commercial land uses are authorized and provided for in the Master Plan Additional Elements and Small Area Plans. Up to 22,000 residential units and 22,000,000 square feet of non-residential uses are allowed by the Master Plan. Residential and non-residential uses will be located generally as depicted in the Master Plan and more specifically as provided in Small Area Plans and site and subdivision plans approved by the Town. Building types will include single family detached dwellings, apartments and other forms of attached residences, mixed-use buildings, offices, and a variety of institutional and commercial structures. Architectural styles and designs will vary within the Chatham Park Planned Development District, but will be context oriented.
View Source

Related to Development Uses

  • Development Phase contractual phase initiated with the approval of ANP for the Development Plan and which is extended during the Production Phase while investments in ▇▇▇▇▇, equipment, and facilities for the Production of Oil and Gas according to the Best Practices of the Oil Industry are required.

  • Development Program A. Development activities to be undertaken (Please break activities into subunits with the date of completion of major milestones) B. Estimated total development time

  • Development Activities The Development activities referred to in item “b” of paragraph 3.1 include: studies and projects of implementation of the Production facilities; drilling and completion of the Producing and injection ▇▇▇▇▇; and installation of equipment and vessels for extraction, collection, Treatment, storage, and transfer of Oil and Gas. The installation referred to in item “c” includes, but is not limited to, offshore platforms, pipelines, Oil and Gas Treatment plants, equipment and facilities for measurement of the inspected Production, wellhead equipment, production pipes, flow lines, tanks, and other facilities exclusively intended for extraction, as well as oil and gas pipelines for Production Outflow and their respective compressor and pumping stations.

  • Development and Commercialization Subject to Sections 4.6 and 4.7, Fibrocell shall be solely responsible for the development and Commercialization of Fibrocell Products and Improved Products. Fibrocell shall be responsible for all costs incurred in connection with the Fibroblast Program except that Intrexon shall be responsible for the following: (a) costs of establishing manufacturing capabilities and facilities in connection with Intrexon’s manufacturing obligation under Section 4.6 (provided, however, that Intrexon may include an allocable portion of such costs, through depreciation and amortization, when calculating the Fully Loaded Cost of manufacturing a Fibrocell Product, to the extent such allocation, depreciation, and amortization is permitted by US GAAP, it being recognized that the majority of non-facilities scale-up costs cannot be capitalized and amortized under US GAAP); (b) costs of basic research with respect to the Intrexon Channel Technology and Intrexon Materials (i.e., platform improvements) but, for clarity, excluding research described in Section 4.7 or research requested by the JSC for the development of a Fibrocell Product or an Improved Product (which research costs shall be reimbursed by Fibrocell); (c) [*****]; and (d) costs of filing, prosecution and maintenance of Intrexon Patents. The costs encompassed within subsection (a) above shall include the scale-up of Intrexon Materials and related active pharmaceutical ingredients for clinical trials and Commercialization of Fibrocell Products undertaken pursuant to Section 4.6, which shall be at Intrexon’s cost whether it elects to conduct such efforts internally or through Third Party contractors retained by either Intrexon or Fibrocell (with Intrexon’s consent).

  • Development Plan document specifying the work program, schedule, and relevant investments required for the Development and the Production of a Discovery or set of Discoveries of Oil and Gas in the Contract Area, including its abandonment.